Description
FORMA FARMACÉUTICA: 1 JARABE
Prevención de eventos cardiovasculares en pacientes con riesgo elevado
DOSIS: 18 MCG
PRINCIPIO ACTIVO: ACIDO HIALURONICO
EFUDIX 0 5% LPS CRA 20G ALLERGAN FORMA FARMACÉUTICA: 1 JARABEPRINCIPIO ACTIVO: IMIQUIMOD 0. 005 DOSIS: 20 G FORMA FARMACUTICA: 1 CREMA PRESENTACIN: 1 TUBO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
